Market Overview

BioScrip to Participate in Upcoming Investor Conferences

Share:

DENVER, Sept. 05, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf, President and Chief Executive Officer, will participate in the following upcoming investor conferences:

The 2nd Annual Lake Street Best Ideas Growth (B.I.G.) Conference
New York, New York
Thursday, September 13, 2018
One-on-one meetings

The 11th Annual Barrington Research Fall Investment Conference
Chicago, Illinois
Thursday, September 27, 2018
One-on-one and small group meetings

Copies of materials used during the meetings will be accessible via BioScrip's Investor Relations website at https://investors.bioscrip.com/.

About BioScrip, Inc.

BioScrip, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,100 teammates and nearly 70 service locations across the U.S. BioScrip partners with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.

Investor Contacts:

Stephen Deitsch                                                            Kalle Ahl, CFA
Chief Financial Officer & Treasurer                               The Equity Group
T:  (720) 697-5200                                                         T:  (212) 836-9614
stephen.deitsch@bioscrip.com                                      kahl@equityny.com

BioScrip Logo.jpg

View Comments and Join the Discussion!